本页面由Tiger Trade Technology Pte. Ltd.提供服务

NEWAMSTERDAM PHARMA CO NV

28.94
-1.5200-4.99%
盘后28.940.00000.00%16:10 EDT
成交量:90.94万
成交额:2,700.10万
市值:33.27亿
市盈率:-16.81
高:31.41
开:30.16
低:28.89
收:30.46
52周最高:42.00
52周最低:14.06
股本:1.15亿
流通股本:6,472.04万
量比:0.94
换手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-1.7211
每股收益(LYR):-1.7211
净资产收益率:-28.29%
总资产收益率:-17.27%
市净率:4.87
市盈率(LYR):-16.81

数据加载中...

2026/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/18

重要事件披露

Form 8-K - Current report
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities